Red Eye Triple Action 0.05 % (Tetrahydrozoline Hydrochloride DROPS) 0.05 %

RED EYE TRIPLE ACTION 0.05% drops provide fast-acting relief for red, irritated eyes. This ophthalmic solution contains tetrahydrozoline hydrochloride, a common decongestant for eye discomfort.

Strength

0.05 %

Manufacturer / TM Owner

KENVUE CANADA INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

RED EYE TRIPLE ACTION 0.05% drops are designed to relieve redness, irritation, and minor eye discomfort. Often used for temporary relief of eye strain or minor irritations, this solution helps reduce redness by constricting blood vessels in the eye. It is commonly sought for its quick action in soothing tired or irritated eyes.

Side Effects

Users of RED EYE TRIPLE ACTION 0.05% drops may experience reduced redness and irritation shortly after application. The effects are typically temporary, providing relief for a few hours. Some users may notice a mild stinging sensation upon initial use, which usually subsides quickly.

Precautions & Warnings

It is important to follow the instructions provided with RED EYE TRIPLE ACTION 0.05% drops to avoid overuse. Prolonged use may lead to rebound redness or other eye discomfort. Avoid contact with soft contact lenses, and remove lenses before application. Consult a healthcare provider if symptoms persist or worsen.

Avoid Interactions

RED EYE TRIPLE ACTION 0.05% drops may interact with other eye medications. It is advisable to wait at least 5-10 minutes between using different eye products. Avoid using this solution while wearing contact lenses, as it may cause discomfort or damage to the lenses.

Frequently Asked Questions

RED EYE TRIPLE ACTION 0.05% drops are used to relieve red, irritated eyes by reducing blood vessel dilation.

Follow the instructions on the packaging or consult a healthcare provider for guidance on usage frequency.

It is recommended to remove contact lenses before using RED EYE TRIPLE ACTION 0.05% drops to avoid potential irritation.

If eye irritation persists or worsens, consult a healthcare provider for further evaluation.

Consult a healthcare provider before using RED EYE TRIPLE ACTION 0.05% drops in children to ensure safety.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.